Cardlytics receives Nasdaq notice after shares trade below $1 for 30 days
Cardlytics, Inc.
Cardlytics, Inc. CDLX | 0.00 |
- Cardlytics received a Nasdaq notice for failing the $1 minimum bid-price rule after 30 straight business days below $1.
- Nasdaq gave the company until Nov. 30, 2026 to regain compliance by closing at or above $1 for 10 consecutive sessions.
- A 1-for-10 reverse stock split takes effect at 5:00 p.m. ET on June 5, 2026; split-adjusted trading starts June 8, 2026.
- Authorized common shares fall to 10 million from 100 million; shares outstanding drop to about 5,807,863 from 58,078,634.
- Failure to regain compliance could trigger a delisting notice, with an option to seek an additional 180-day cure period or appeal.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cardlytics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-040351), on June 03, 2026, and is solely responsible for the information contained therein.
